Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

7.79p
   
  • Change Today:
      0.21p
  • 52 Week High: 13.80
  • 52 Week Low: 7.23
  • Currency: UK Pounds
  • Shares Issued: 250.22m
  • Volume: 168,186
  • Market Cap: 19.49m
  • RiskGrade: 328

Immupharma Overview

Immupharma is in the pharma and biotech sector and is currently trading at 7.79p per share. In the last year Immupharma's share price has ranged from 7.23p to 13.80p.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -4300.0% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 149.9 n/a
Pr/Book 2.0  
Latest F'cast
Revenue 62.5% -100.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Immupharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-16 0.16 (6.31) (4.54)p n/a n/a n/a n/a 0.0%
31-Dec-17 0.15 (7.00) (4.75)p n/a n/a n/a n/a 0.0%
31-Dec-18 0.08 (7.96) (5.19)p n/a n/a n/a n/a 0.0%
31-Dec-19 0.08 (6.74) (3.99)p n/a n/a n/a n/a 0.0%
31-Dec-20 0.13 (7.25) (3.43)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Immupharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 n/a n/a n/a n/a n/a n/a n/a 0.0%
31-Dec-22 n/a n/a n/a n/a n/a n/a n/a 0.0%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

Immupharma Company Announcements

Director/PDMR Shareholding 24-Aug-2021 11:07 RNS
Second Price Monitoring Extn 20-Aug-2021 16:40 RNS
Price Monitoring Extension 20-Aug-2021 16:35 RNS

Latest Immupharma Director Deals

Traded Action Notifier PriceAmountValue
24-Aug-21 Buy Tim Franklin 8.26p 125,000 10,325.00
23-Aug-21 Buy Timothy Paul McCarthy 8.26p 250,000 20,650.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Immupharma Market Data

Currency UK Pounds
Share Price 7.79p
Change Today 0.21p
% Change 2.77 %
52 Week High 13.80
52 Week Low 7.23
Volume 168,186
Shares Issued 250.22m
Market Cap 19.49m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
43.07% below the market average43.07% below the market average43.07% below the market average43.07% below the market average43.07% below the market average
52.00% above the sector average52.00% above the sector average52.00% above the sector average52.00% above the sector average52.00% above the sector average
Price Trend
80.24% below the market average80.24% below the market average80.24% below the market average80.24% below the market average80.24% below the market average
77.42% below the sector average77.42% below the sector average77.42% below the sector average77.42% below the sector average77.42% below the sector average
Income Not Available
Growth
41.60% above the market average41.60% above the market average41.60% above the market average41.60% above the market average41.60% above the market average
5.56% above the sector average5.56% above the sector average5.56% above the sector average5.56% above the sector average5.56% above the sector average

Immupharma Dividends

No dividends found

Trades for 17-Sep-2021

Time Volume / Share Price
11:31 4,500 @ 7.90p
11:28 450 @ 7.80p
11:21 6,100 @ 7.90p
11:21 6,100 @ 7.90p
11:06 6,100 @ 7.94p

Immupharma Key Personnel

CEO Dimitri Dimitriou

Top of Page